St Vincent's University Hospital

At St Vincent's University Hospital, the Cardiology team is running studies in cardiovascular disease and chronic heart failure, with an emphasis on improving symptoms, slowing disease progression, and lowering the risk of serious heart events.

• Testing new treatments for heart failure with reduced ejection fraction
• Studying therapies for early-stage heart dysfunction and prevention
• Evaluating ways to reduce cardiovascular death and hospital admissions

These trials aim to refine treatment options for people living with complex heart disease and to support better long-term outcomes.

The site is active in a broad range of cancer studies, including breast cancer, lung cancer, prostate cancer, colorectal cancer, gastric cancer, renal cell carcinoma, and melanoma. The research focuses on testing new therapies and improving survival in advanced or high-risk disease.

• Evaluating targeted and immune-based treatments for advanced cancers
• Studying therapy combinations for breast, lung, and prostate cancers
• Assessing approaches to delay progression and extend survival

This oncology portfolio reflects a strong interest in both newly diagnosed and previously treated cancers, with several studies aimed at improving outcomes after standard therapy.

Research in digestive system diseases includes studies of Crohn's disease, ulcerative colitis, and celiac disease, alongside work in gastrointestinal cancers. The goal is to improve disease control, maintain remission, and better understand treatment benefit over time.

• Testing maintenance therapies for Crohn's disease
• Comparing treatments for ulcerative colitis
• Investigating new approaches for celiac disease

These studies support more personalized care for patients with chronic intestinal inflammation and related digestive disorders.

The hospital also contributes to research in nervous system diseases, including multiple sclerosis and Alzheimer's disease. Trials here are designed to test whether new treatments can better control relapse activity or preserve cognition and daily function.

• Studying relapsing multiple sclerosis treatments
• Evaluating therapies for mild cognitive impairment and early dementia
• Exploring options to slow neurological decline

Work in this area combines symptom control with efforts to protect long-term brain health.

Clinical trials at the site include research on COVID-19 and Mpox infection, reflecting ongoing interest in virus diseases and hospital-based response to emerging infections. These studies focus on improving treatment and prevention.

• Testing therapies for hospitalized adults with COVID-19
• Evaluating vaccination strategies for Mpox
• Supporting better management of acute viral infections

This area highlights the role of St Vincent's University Hospital in responding to infectious threats with practical clinical research.

Additional trials span nutritional and metabolic diseases, immune system diseases, and other specialized conditions, including pre-heart failure, mild cognitive impairment, and treatment-related symptoms in cancer care. The common thread is improving quality of life and testing whether new strategies can better support patients across different conditions.

• Exploring treatments for early metabolic and cardiac risk states
• Studying symptom relief in people receiving cancer therapy
• Assessing new options for immune-mediated and rare conditions

This diverse research mix shows a broad clinical trial profile beyond the hospital's core cardiology focus.